3-(2,4-DIOXOTETRAHYDROPYRIMIDIN-1(2H)-YL)BENZOIC ACID, 95%, 250mg

5'-O-DMT-rI, 100mg

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 95+%, 250mg

Methyl p-Tolylacetate>99.0%(GC)25g

(1,10-Phenanthroline)(trifluoromethyl)(triphenylphosphine)copper(I)>95.0%(T)5g

3-(1,3-Benzothiazol-2-ylthio)propanoic acid, 97.0%, 10g

(4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 96%, 5g

[1-(thiophen-2-yl)cyclohexyl]methanamine, 98%, 10g

D-Valine>98.0%(T)1g

4-Chloro-3-methanesulfonylbenzoic acid, 250mg

3-iodo-5-(1H-pyrazol-3-yl)-1H-pyrazole, 5g

3-(4-tert-Butyl-2,6-dimethylphenyl)-2-methyl-1-propene, 97.0%, 1g

1,4-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 25g